Is a complete BVMF/BIIB34 research report available?

No complete published report is available for bvmf/BIIB34 (BVMF/BIIB34) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/BIIB34 (BVMF/BIIB34)

Brazil Stock Exchange: BVMF/BIIB34 · BRL

R$194

+0.00 (0.0%)· Recorded snapshot

Market cap	199.7B
Revenue (ttm)	53.3B
Net income (ttm)	1.8B
EPS (ttm)	R$2.09
P/E (trailing)	92.7x
P/E (forward)	16.2x
Volume	0
Beta	0.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 53.3B
Net income (ttm): 1.8B
EPS (ttm): R$2.09
P/E (trailing): 92.7x
P/E (forward): 16.2x
Market cap: 199.7B

Metric	Value
Amount currency	BRL
Country	United States
Country code	BR
Earnings date	2026-10-28
Employees	7,500
Employees change	-105
Employees growth	-1.38%
Enterprise value	BRL 237.5B
Exchange	Brazil Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1978
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	BRBIIBBDR001
Last earnings date	2026-10-28
Last refreshed	2026-10-28
Market cap	BRL 199.7B
Next earnings date	2026-10-28
Price	BRL 193.80
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-14
Symbol	bvmf/BIIB34
Website	https://www.biogen.com

Metric

Value

Amount currency

BRL

Country

United States

Country code

Earnings date

2026-10-28

Employees

7,500

Employees change

-105

Employees growth

-1.38%

Enterprise value

BRL 237.5B

Exchange

Brazil Stock Exchange

Financial currency

USD

Financial report date

2026-09-30

First seen

2026-05-10

Fiscal year end

December

Founded

1978

Industry

Drug Manufacturers - General

Is primary listing

ISIN number

BRBIIBBDR001

Last earnings date

2026-10-28

Last refreshed

2026-10-28

Market cap

BRL 199.7B

Next earnings date

2026-10-28

Price

BRL 193.80

Price currency

BRL

Sector

Healthcare

SIC code

2836

Stock price date

2026-10-14

Symbol

bvmf/BIIB34

Website

https://www.biogen.com

Metric	Value
Average P/E ratio (10Y)	19.56x
Average P/E ratio (3Y)	27.63x
Average P/E ratio (5Y)	23.52x
Earnings yield	1.08%
EV/Earnings	131.93x
EV/EBIT	23.3x
EV/EBITDA	14.79x
EV/FCF	22.14x
EV/Sales	4.31x
FCF / EV yield	4.52%
FCF yield	5.37%
Forward P/E	16.22x
Graham number	61.15363
Graham upside	-68.44%
Lynch fair value	BRL 8.74
Lynch upside	-95.49%
P/(FCF - SBC) ratio	21.8x
P/(OCF - SBC) ratio	19.82x
P/B ratio	2.04x
P/E ratio	92.74x
P/FCF ratio	18.62x
P/OCF ratio	17.15x
P/S ratio	3.74x
Price/EBITDA ratio	13.82x
Sector forward P/E	11.27x
Sector P/E	41.78x

Metric

Value

Average P/E ratio (10Y)

19.56x

Average P/E ratio (3Y)

27.63x

Average P/E ratio (5Y)

23.52x

Earnings yield

1.08%

EV/Earnings

131.93x

EV/EBIT

23.3x

EV/EBITDA

14.79x

EV/FCF

22.14x

EV/Sales

4.31x

FCF / EV yield

4.52%

FCF yield

5.37%

Forward P/E

16.22x

Graham number

61.15363

Graham upside

-68.44%

Lynch fair value

BRL 8.74

Lynch upside

-95.49%

P/(FCF - SBC) ratio

21.8x

P/(OCF - SBC) ratio

19.82x

P/B ratio

2.04x

P/E ratio

92.74x

P/FCF ratio

18.62x

P/OCF ratio

17.15x

P/S ratio

3.74x

Price/EBITDA ratio

13.82x

Sector forward P/E

11.27x

Sector P/E

41.78x

Metric	Value
EBIT margin	18.51%
EBITDA margin	27.08%
Effective tax rate	21.93%
FCF margin	19.39%
Gross margin	74.46%
Operating margin	18.51%
Pretax margin	4.32%
Profit margin	3.37%
Profit per employee	BRL 240,002
Profitable quarters	2
Profitable years	22
Revenue per employee	BRL 7.1M
ROA	3.89%
ROA (5Y)	6.68%
ROCE	6.77%
ROE	1.87%
ROE (5Y)	13.26%
ROIC	5.8%
ROIC (5Y)	13.87%
SBC / revenue	2.94%
Tax / revenue	0.95%

Metric

Value

EBIT margin

18.51%

EBITDA margin

27.08%

Effective tax rate

21.93%

FCF margin

19.39%

Gross margin

74.46%

Operating margin

18.51%

Pretax margin

4.32%

Profit margin

3.37%

Profit per employee

BRL 240,002

Profitable quarters

Profitable years

Revenue per employee

BRL 7.1M

ROA

3.89%

ROA (5Y)

6.68%

ROCE

6.77%

ROE

1.87%

ROE (5Y)

13.26%

ROIC

5.8%

ROIC (5Y)

13.87%

SBC / revenue

2.94%

Tax / revenue

0.95%

Metric	Value
EPS growth	-78.73%
EPS growth 10Y	-18.33%
EPS growth 3Y	-38.53%
EPS growth 5Y	-25.57%
EPS growth years	0
FCF growth	-10.14%
FCF growth (Q)	-51.04%
FCF growth (QoQ)	47.16%
FCF growth 3Y	24.95%
FCF growth 5Y	-0.67%
Gross profit growth	-2.8%
Gross profit growth (Q)	1.46%
Gross profit growth 3Y	0.71%
Gross profit growth 5Y	-3.49%
Net income growth	-78.4%
Net income growth 3Y	-38.05%
Net income growth 5Y	-25.81%
Net income growth years	0
OCF growth	-8.42%
OCF growth (Q)	-49.64%
OCF growth (QoQ)	42.75%
OCF growth 10Y	-5.71%
OCF growth 3Y	18.23%
OCF growth 5Y	-1.59%
Operating income growth	-34.8%
Operating income growth (Q)	-38.47%
Operating income growth 3Y	-2.65%
Operating income growth 5Y	-5.69%
Revenue growth	2.3%
Revenue growth (Q)	10.63%
Revenue growth (QoQ)	2.49%
Revenue growth 10Y	-1.03%
Revenue growth 3Y	1%
Revenue growth 5Y	-1.49%
Revenue growth quarters	2
Revenue growth years	1

Metric

Value

EPS growth

-78.73%

EPS growth 10Y

-18.33%

EPS growth 3Y

-38.53%

EPS growth 5Y

-25.57%

EPS growth years

FCF growth

-10.14%

FCF growth (Q)

-51.04%

FCF growth (QoQ)

47.16%

FCF growth 3Y

24.95%

FCF growth 5Y

-0.67%

Gross profit growth

-2.8%

Gross profit growth (Q)

1.46%

Gross profit growth 3Y

0.71%

Gross profit growth 5Y

-3.49%

Net income growth

-78.4%

Net income growth 3Y

-38.05%

Net income growth 5Y

-25.81%

Net income growth years

OCF growth

-8.42%

OCF growth (Q)

-49.64%

OCF growth (QoQ)

42.75%

OCF growth 10Y

-5.71%

OCF growth 3Y

18.23%

OCF growth 5Y

-1.59%

Operating income growth

-34.8%

Operating income growth (Q)

-38.47%

Operating income growth 3Y

-2.65%

Operating income growth 5Y

-5.69%

Revenue growth

2.3%

Revenue growth (Q)

10.63%

Revenue growth (QoQ)

2.49%

Revenue growth 10Y

-1.03%

Revenue growth 3Y

Revenue growth 5Y

-1.49%

Revenue growth quarters

Revenue growth years

Metric	Value
Capital expenditures	BRL -913.7M
Depreciation and amortization	BRL 4.7B
EBIT	BRL 9.9B
EBITDA	BRL 14.4B
EPS	BRL 2.09
Financing cash flow	BRL 3.7B
Free cash flow	BRL 10.7B
Free cash flow minus SBC	BRL 9.2B
Gross profit	BRL 39.7B
Income taxes	BRL 505.6M
Investing cash flow	BRL -28.5B
Net borrowing	BRL 3.3B
Net cash flow	BRL -13.3B
Net income	BRL 1.8B
Operating cash flow minus SBC	BRL 10.1B
Operating income	BRL 9.9B
Revenue	BRL 53.3B
Stock-based compensation	BRL 1.6B

Metric

Value

Capital expenditures

BRL -913.7M

Depreciation and amortization

BRL 4.7B

EBIT

BRL 9.9B

EBITDA

BRL 14.4B

EPS

BRL 2.09

Financing cash flow

BRL 3.7B

Free cash flow

BRL 10.7B

Free cash flow minus SBC

BRL 9.2B

Gross profit

BRL 39.7B

Income taxes

BRL 505.6M

Investing cash flow

BRL -28.5B

Net borrowing

BRL 3.3B

Net cash flow

BRL -13.3B

Net income

BRL 1.8B

Operating cash flow minus SBC

BRL 10.1B

Operating income

BRL 9.9B

Revenue

BRL 53.3B

Stock-based compensation

BRL 1.6B

Metric	Value
Book value per share	BRL 663.07
Debt / EBITDA	2.6
Debt / equity	0.41
Debt / FCF	3.77
Goodwill	BRL 37.6B
Interest coverage	28.24
Long-term assets	BRL 125.3B
Long-term liabilities	BRL 47.1B
Net cash (debt)	BRL -33.7B
Net cash / market cap	-16.86%
Net debt / EBITDA	2.33
Net debt / equity	0.34
Net debt / FCF	3.14
Piotroski F-Score	4
Property, plant and equipment	BRL 16.9B
Shareholders' equity	BRL 98B
Tangible book value	BRL -7.5B
Tangible book value per share	BRL -50.82
Total assets	BRL 166B
Total cash	BRL 6.8B
Total debt	BRL 40.4B
Total liabilities	BRL 68B
WACC	4.07%

Metric

Value

Book value per share

BRL 663.07

Debt / EBITDA

2.6

Debt / equity

0.41

Debt / FCF

3.77

Goodwill

BRL 37.6B

Interest coverage

28.24

Long-term assets

BRL 125.3B

Long-term liabilities

BRL 47.1B

Net cash (debt)

BRL -33.7B

Net cash / market cap

-16.86%

Net debt / EBITDA

2.33

Net debt / equity

0.34

Net debt / FCF

3.14

Piotroski F-Score

Property, plant and equipment

BRL 16.9B

Shareholders' equity

BRL 98B

Tangible book value

BRL -7.5B

Tangible book value per share

BRL -50.82

Total assets

BRL 166B

Total cash

BRL 6.8B

Total debt

BRL 40.4B

Total liabilities

BRL 68B

WACC

4.07%

Metric	Value
Asset turnover	0.34
Current assets	BRL 40.7B
Current liabilities	BRL 20.9B
Current ratio	1.95
Inventory turnover	1.19
Net working capital	BRL 14.4B
Quick ratio	0.95
Working capital	BRL 19.1B
Working capital turnover	11.43

Metric

Value

Asset turnover

0.34

Current assets

BRL 40.7B

Current liabilities

BRL 20.9B

Current ratio

1.95

Inventory turnover

1.19

Net working capital

BRL 14.4B

Quick ratio

0.95

Working capital

BRL 19.1B

Working capital turnover

11.43

Metric	Value
Buyback yield / dilution	-1.45%
Shareholder yield	-1.45%

Metric

Value

Buyback yield / dilution

-1.45%

Shareholder yield

-1.45%

Metric	Value
10Y price change	18.82%
10Y return CAGR	1.74%
10Y total return	18.82%
150-day SMA	BRL 149.06
1D price change	0%
1M price change	2.93%
1M total return	2.93%
1W price change	5.05%
1W total return	5.05%
1Y price change	45.02%
1Y return CAGR	45.05%
1Y total return	45.02%
20-day SMA	BRL 179.27
200-day SMA	BRL 144.91
3M price change	13.77%
3M total return	13.77%
3Y price change	-6.15%
3Y return CAGR	-2.09%
3Y total return	-6.15%
50-day SMA	BRL 167.18
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 193.80
52-week high date	2026-10-14
52-week low	BRL 128.69
52-week low date	2025-10-20
5Y price change	-25.95%
5Y return CAGR	-5.83%
5Y total return	-25.95%
6M price change	29.46%
6M total return	29.46%
All-time high	BRL 360.00
All-time high date	2020-11-06
All-time low	BRL 110.07
All-time low date	2025-04-10
Average true range (ATR)	BRL 4.33
Average volume	101
Beta (5Y)	0.09
Change from 52-week high	0%
Change from 52-week low	50.59%
Change from all-time high	-46.17%
Change from all-time low	76.07%
Change from open	0%
Day's gap	0%
High price	BRL 193.80
Low price	BRL 193.80
Monthly RSI	62.72
Open price	BRL 193.80
Previous close	BRL 193.80
Price vs 150-day SMA	30.01%
Price vs 20-day SMA	8.11%
Price vs 200-day SMA	33.74%
Price vs 50-day SMA	15.93%
Relative volume	0.27
RSI	66.69
Sharpe ratio	-0.08
Sharpe ratio (3Y)	0.1
Sortino ratio	0.01
Sortino ratio (3Y)	0.28
Volume	0
Weekly RSI	63.25
YTD price change	20.37%
YTD total return	20.37%

Metric

Value

10Y price change

18.82%

10Y return CAGR

1.74%

10Y total return

18.82%

150-day SMA

BRL 149.06

1D price change

1M price change

2.93%

1M total return

2.93%

1W price change

5.05%

1W total return

5.05%

1Y price change

45.02%

1Y return CAGR

45.05%

1Y total return

45.02%

20-day SMA

BRL 179.27

200-day SMA

BRL 144.91

3M price change

13.77%

3M total return

13.77%

3Y price change

-6.15%

3Y return CAGR

-2.09%

3Y total return

-6.15%

50-day SMA

BRL 167.18

50-day SMA vs 200-day SMA

50over200

52-week high

BRL 193.80

52-week high date

2026-10-14

52-week low

BRL 128.69

52-week low date

2025-10-20

5Y price change

-25.95%

5Y return CAGR

-5.83%

5Y total return

-25.95%

6M price change

29.46%

6M total return

29.46%

All-time high

BRL 360.00

All-time high date

2020-11-06

All-time low

BRL 110.07

All-time low date

2025-04-10

Average true range (ATR)

BRL 4.33

Average volume

101

Beta (5Y)

0.09

Change from 52-week high

Change from 52-week low

50.59%

Change from all-time high

-46.17%

Change from all-time low

76.07%

Change from open

Day's gap

High price

BRL 193.80

Low price

BRL 193.80

Monthly RSI

62.72

Open price

BRL 193.80

Previous close

BRL 193.80

Price vs 150-day SMA

30.01%

Price vs 20-day SMA

8.11%

Price vs 200-day SMA

33.74%

Price vs 50-day SMA

15.93%

Relative volume

0.27

RSI

66.69

Sharpe ratio

-0.08

Sharpe ratio (3Y)

0.1

Sortino ratio

0.01

Sortino ratio (3Y)

0.28

Volume

Weekly RSI

63.25

YTD price change

20.37%

YTD total return

20.37%

Metric	Value
Float	147.2M
Shares change (QoQ)	-0.61%
Shares change (YoY)	1.45%
Shares held by insiders	0.21%
Shares held by institutions	97.68%

Metric

Value

Float

147.2M

Shares change (QoQ)

-0.61%

Shares change (YoY)

1.45%

Shares held by insiders

0.21%

Shares held by institutions

97.68%

BVMF/BIIB34 (BVMF/BIIB34)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/BIIB34

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/BIIB34 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/BIIB34

Frequently asked questions